About Bhawks? - A Love of Hate: The Addiction of the New

New Post Public Reply Private Reply Replies (1) Message Board
PoemStone cashclan #17722
176
About Bhawks? - A Love of Hate:
The Addiction of the New American Left
By Pete Vanderzwet
February 4, 2017

"No Trump! No KKK! No Fascist USA!".



Damning. Morally righteous. A call to arms against darkness. This is how the new American left views itself and its opposition to President Donald Trump: a bulwark against a perceived tide of evil, where only leftists' pink hats and calls to #resist stand a chance to prevent a historic cataclysm from a caricature of an administration believed to embody all the elements necessary to be categorized as evil.

After all, didn't senior counselor to the president Steve Bannon openly admit that "darkness is good"?

Reaction to Bannon's quote exemplifies the emotional jockeying of Democrats and their supporters. Objectivity, reasoned analysis of source material, and primary research take a back seat when weighed against the desire to dislike someone if only to identify yourself to others as against what all normal people are against.

The former naval officer, who once served as an assistant to the chief of naval operations at the Pentagon, more fully stated:

Darkness is good. Dick Cheney. Darth Vader. Satan. That's power. It only helps us when they [the media] get it wrong. When they're blind to who we are and what we're doing.

In other words, when the media and its adherents so blindly and gleefully accept you as the totality of evil, it significantly raises your moral stock when you do anything marginally ordinary. They put you in a narrative where the standards are so low that you cannot help but succeed.

This simplification and eagerness to be outraged are enjoyed and have in large part become the hallmark of the current American left. There is a scientific neurological reason behind the propensity in politics to emotionally simplify the position of your opposition – or, in President Trump's case, dehumanize him entirely as a symbol of what you fantasize about fighting.

In a study published by Neuroreport in 2010, Rajendra D. Badgaiyan from the Department of Psychiatry at the University of Buffalo found evidence that "dopamine is released during processing of negative emotions." How symptomatic is the current level of discourse in American politics, and the outrage culture on the left in particular, of a dopamine addiction fueled by the experience of negative emotions such as anger and excited outrage? Further, how actively is this outrage sought when presented with a draught of cherished anger? How willing is one with such an addiction to fabricate or manipulate statements and events to generate conditions wherein that satisfaction may be found?

We see this in the left's interaction with Bannon's quote. Or Kellyanne Conway's exhausted interview with Chuck Todd on Meet the Press early in the morning after President Trump's inauguration. Obviously, there is no such thing as an "alternative fact," but there are alternative data and alternative sources of data. Rather than give the normally exceptionally articulate Conway the benefit of the doubt with her error, the media pounced. The left pounced. They loved it. They're still loving it.

Where is the desire for objectivity? Balanced and nuanced thought? An observation of context before a leap for emotional satisfaction?

One would think the organizers of the well attended "Women's March" would be praising Conway as a champion for women in politics, with her meteoric rise and highly praised management of Trump's presidential campaign, but here there is only silence – at least from the self-proclaimed champions of women on the left. Can this be explained in part by a desire to produce an atmosphere of outrage in an effort to generate dopamine? Praise induces less feedback, socially and emotionally, than maintaining a position of (rarely righteous) indignation.

The optics of the Women's March as a whole are also relevant here. Solidarity, a general concern for women's rights, and a belief that "women's rights are human rights" were cited by the organizers and participants as the driving force behind the march. It was portrayed as a universal experience for women, an act of solidarity for female causes, and #resistance to measures they believe are being put in place to limit them. The problem is that half of American women disagree with their core stance on abortion, yet the organizers portrayed their event as being representative of their gender as a monolith. There is a perceived moral monopoly, the disagreement with which is met not only with outrage, but with visceral anger that seems to be very much enjoyed.

President Trump's administration did not remove the bust of Dr. Martin Luther King, Jr. Accurate retraction of this error took a secondary role to the potential for what would have been a hateful, racist act.

USDA scientists were not gagged or put "on lockdown" by the president, as is still widely being reported, but were subject to the same conditions imposed on them by the transitional team of President Obama. Cue the outraged "March for Science" – disappointing, since it is this group whom one would expect to read primary material before forming a conclusion.

Deliberate, precise, objective, and rational approaches to the digestion of information are not nearly as rewarding as emotional reaction.

The most extreme examples of this apparent addiction is the reduction of all arguments or opposition to a position as resulting from an adherence to neo-Nazism. This is the ultimate expression of the phenomenon where a desire to experience anger is so great that one simply discards rationality and skips to utter dehumanization of an opponent to experience the chemical reward generated by manufactured anger. Ironically, this is a well understood tactic employed by the Nazi Reich minister of propaganda.

There are significant parallels between the current political environment and early Nazi Germany, but they do not run along President Donald Trump's policies. On the left, fabricated outrage has met opposition to leftist positions with violence similar to the behavior of the S.A., the forerunner of the more well-known Schutzstaffel. As people quested to find a label to gleefully hate, Google searches for "fascism" exploded in November 2016, with those doing the searching unaware that their authoritarian behavior lies more with the ideology they've made such an effort to show others they're against.

Now this recreational outrage transitions to Trump's pick for the Supreme Court of the United States, Neil Gorsuch, who until his nomination was admired by all sides. In an effort to beat them to the punch, a supporter of President Trump's pick immediately congratulated Gorsuch "on becoming a racist, sexist, homophobic, Islamophobic, xenophobic white male." With an addiction to outrage well entrenched on the side of his opposition, we can only assume that such accusations are forthcoming.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cepheid's FDA Clearance Boosts Hemorrhagic Fever Test

Updated Category News Views 81

Quick Detection for Deadly Viruses In the world of diagnostics, speed isn't just a luxury; it's a lifeline. Cepheid’s latest move—getting the FDA’s nod for their Xpert Hemorrhagic Fever Panel Test—is a big deal. Why? Imagine being able to detect nasty viruses like Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever in just over an hour. That's what this...

Continue Reading
Icahn Faces $225M Q3 Loss, But CVR Deal Shines

Updated Category News Views 30

Icahn Enterprises Stumbles in Q3, Losses Widen When a company's financial report starts with a loss, it's like stepping into a bar fight expecting cheers—you’re bound to get more than you bargained for. Icahn Enterprises L.P.'s third quarter report isn't exactly a rosy picture. We're staring down the barrel of a net loss of $225 million, a sharp contrast to the $287...

Continue Reading
MINISO Prepares to Reveal September 2026 Results

Updated Category News Views 74

News flash, folks — MINISO Group, that quirky IP-driven retailer we all have an eye on, has set the stage for its next big reveal. Come November 17, 2026, they’re gonna lay down their financial cards for the September quarter. It’s prime time for any investor keen on dissecting their performance and plans for the future. What the Call Means for Stakeholders MINISO's...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 57

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading
Doximity Faces Class Action: Investor Guidance Needed

Updated Category News Views 37

Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...

Continue Reading
RepData's New Platform Redefines Market Research Game

Updated Category News Views 34

Ever look at your market research and think, 'Is this really the best we can do?' RepData just rolled up like they own the place with their Verified Intelligence Platform (VIP), promising to make those wild data quality doubts a thing of the past. RepData’s Game-Changer in Research RepData's stepping into the ring with their VIP, aiming to shake up the way research...

Continue Reading
Oracle's $20 Billion Offering: What Investors Need to Know

Updated Category News Views 118

Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...

Continue Reading
PRIMA Invests £10M to Propel CC Forum's Global Reach

Updated Category News Views 98

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Continue Reading
Handle Plumbing Emergencies Swiftly, Expert Advises

Updated Category News Views 49

Fast Response Crucial in Plumbing Crises It's like nature's way of testing your mettle: a sudden plumbing emergency can make any homeowner feel like they're in over their head. The trick lies in how fast you act, and let me tell you, speed is everything in these situations. If you’ve never stared down a burst pipe or felt your heart drop at an overflowing toilet,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth and Trends in Nuclear Medicine

Updated Category News Views 326

Nuclear Medicine Market Trends and Growth Projections Nuclear medicine is becoming an essential part of modern healthcare systems, offering significant diagnostic and therapeutic benefits. Recent industry analysis shows that the nuclear medicine market, valued at US$ 5.2 billion in 2022, is projected to grow to an astounding US$ 11.4 billion by 2031. This growth...

Continue Reading
Bitcoin Resilience: Experts Forecast Continued Growth Amid Dip

Updated Category News Views 107

Experts Forecast Bitcoin's Continued Growth In recent discussions, cryptocurrency experts have expressed a common belief that Bitcoin's long-term trajectory remains robust despite current fluctuations. Bitcoin has faced challenges in the short term, but the overarching consensus suggests that its bull market is far from over. The Impact of Federal Reserve Policies...

Continue Reading
Iovance Investors Urged to Act Before the July 14 Deadline

Updated Category News Views 170

Important Notice for Iovance Investors Levi & Korsinsky, LLP is reaching out to investors of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) regarding a class action securities lawsuit. This notice serves to inform shareholders of the impending deadline for becoming a lead plaintiff, which is set for July 14, 2025. Class Action Overview The legal action aims to recover...

Continue Reading
Startek® South Africa Achieves Best Employer Brand Award

Updated Category News Views 256

Startek® South Africa Celebrates Employer Branding Success Startek®, a leader in global customer experience solutions, is making waves in the industry with its recent accolade at the South Africa Leadership Awards. Startek's South Africa operations received the prestigious Best Employer Brand Award for 2025, recognizing their exceptional approach to employee engagement...

Continue Reading
ESS Tech Launches Energy Center™ Product for Sustainable Energy

Updated Category News Views 220

ESS Tech Introduces Energy Center™ Product ESS Tech, Inc. (NYSE: GWH), a frontrunner in the field of long-duration energy storage systems, has proudly announced the commercial launch of its innovative Energy Center™ product. This milestone comes with the successful delivery of multiple systems to a prominent utility in Florida, along with the completion of...

Continue Reading